We are happy to introduce Axol Bioscience!

 

Axol Bioscience believes that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. They use human iPSCs to achieve this and have been doing so for over a decade.

They take cells from patient and healthy donors and, using their leading iPSC technology, work with researchers to build physiologically relevant in vitro models. They have a special focus on neurodegenerative diseases, such as Alzheimer’s Disease, as well as cardiotoxicity to promote drug safety.

 

axoCells™

With over a decade of experience, Axol has developed the manufacturing capabilities to produce high-quality, functional iPSC-derived cells with excellent consistency. Your research can benefit from their quality-focused approach, with a catalog of iPSC-derived neurons, neuroinflammatory cells, muscle cells, and cardiomyocytes manufactured at their ISO 9001:2015-accredited production facility.

axoCells cell types:

  • cortical excitatory neurons
  • striatal neurons
  • cortical inhibitory interneurons
  • sensory neurons
  • motor neurons
  • neuroinflammatory cells (microglia and astrocytes)
  • cardiac cells (atrial and ventricular cardiomyocytes)
  • muscle cells (skeletal myotubes)

Key therapy areas include:

  • Alzheimer's disease
  • Parkinson's disease
  • ALS
  • Huntington's disease
  • Friedreich's ataxia
  • Frontotemporal dementia

Browse all products from Axol

 

Contact us